Report Cuba - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Apr 1, 2024

Cuba - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Cuba: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Cuba

The Cuban medicaments containing insulin market totaled less than $X in 2021, remaining constant against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption showed a relatively flat trend pattern.

Medicaments Containing Insulin Exports

Exports from Cuba

Medicaments containing insulin exports from Cuba totaled less than X kg in 2021, almost unchanged from 2020 figures. Overall, exports continue to indicate a relatively flat trend pattern.

In value terms, medicaments containing insulin exports amounted to less than $X in 2021. Over the period under review, exports continue to indicate a relatively flat trend pattern.

Exports by Country

The United States prevails in exports structure, accounting for X tons, which was approx. 92% of total exports in 2021. It was distantly followed by , committing a 0% share of total exports. Thailand (X tons), the Netherlands (X tons), India (X tons) and Denmark (X tons) took a little share of total exports.

Exports from the United States increased at an average annual rate of +13.1% from 2012 to 2021. At the same time, Thailand (+102.4%) displayed positive paces of growth. Moreover, Thailand emerged as the fastest-growing exporter exported in the world, with a CAGR of +102.4% from 2012-2021. Germany experienced a relatively flat trend pattern. By contrast, Denmark (-24.5%), India (-35.1%) and the Netherlands (-73.3%) illustrated a downward trend over the same period. From 2012 to 2021, the share of the United States and Thailand increased by +39 and +2.7 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) remains the largest medicaments containing insulin supplier from Cuba, comprising 84% of global exports. The second position in the ranking was taken by Thailand ($X), with a 0.6% share of global exports. It was followed by Denmark, with a 0.5% share.

From 2012 to 2021, the average annual rate of growth in terms of value in the United States totaled -6.6%. In the other countries, the average annual rates were as follows: Thailand (+48.3% per year) and Denmark (-36.9% per year).

Export Prices by Country

In 2021, the export price in Cuba amounted to less than $X per ton, remaining constant against the previous year. Overall, the export price saw a relatively flat trend pattern.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Netherlands (+114.8%), while the other leaders experienced mixed trends in the export price figures.

Medicaments Containing Insulin Imports

Imports into Cuba

Medicaments containing insulin imports into Cuba stood at X kg in 2021, flattening at the year before. In general, imports continue to indicate a relatively flat trend pattern. Over the period under review, imports reached the maximum in 2021 and are likely to see gradual growth in the immediate term.

In value terms, medicaments containing insulin imports stood at $X in 2021. Over the period under review, imports continue to indicate a relatively flat trend pattern. Cuba imports peaked in 2021 and are likely to see steady growth in the immediate term.

Imports by Country

In 2021, Denmark (X tons) represented the largest importers of medicaments containing insulin but not antibioticsacross the globe, together comprising 67% of total imports. Brazil (X tons) took the next position in the ranking, followed by Malaysia (X tons) and Russia (X tons). All these countries together held approx. 12% share of total imports. Nigeria (X tons), Kuwait (X tons), Ethiopia (X tons), Japan (X tons), China (X tons) and Tunisia (X tons) took a minor share of total imports.

From 2012 to 2021, average annual rates of growth with regard to medicaments containing insulin but not antibiotics imports into Denmark and Italy stood at +27.5% and -41.4%, respectively. At the same time, Brazil (+42.6%), Japan (+32.4%), Ethiopia (+17.3%), Kuwait (+8.8%) and Malaysia (+2.0%) displayed positive paces of growth. Moreover, Brazil emerged as the fastest-growing importer imported in the world, with a CAGR of +42.6% from 2012-2021. By contrast, Nigeria (-2.5%), Tunisia (-22.6%), Russia (-41.8%) and China (-47.3%) illustrated a downward trend over the same period. From 2012 to 2021, the share of Denmark, Brazil, Malaysia, Kuwait, Nigeria, Ethiopia and Japan increased by +67, +6.7, +3.8, +2.5, +2, +2 and +1.6 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics into Cuba, comprising 66% of global imports. The second position in the ranking was held by Brazil ($X), with a 6.3% share of global imports. It was followed by Russia, with a 5.7% share.

From 2012 to 2021, the average annual rate of growth in terms of value in Denmark totaled +20.7%. The remaining importing countries recorded the following average annual rates of imports growth: Brazil (+37.4% per year) and Russia (-27.6% per year).

Import Prices by Country

In 2021, the import price in Cuba amounted to $X per ton, almost unchanged from the previous year. Over the period under review, the import price recorded a relatively flat trend pattern. Cuba import price peaked in 2021 and is likely to see gradual growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Russia ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+24.4%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of consumption in 2021 were the United States, Denmark and Germany, with a combined 72% share of global consumption.
The United States constituted the country with the largest volume of medicaments containing insulin production, accounting for 67% of total volume. Moreover, medicaments containing insulin production in the United States exceeded the figures recorded by the second-largest producer, Germany, fivefold. The third position in this ranking was held by India, with a 5% share.
In value terms, Denmark constitutes the largest market for imported medicaments containing insulin but not antibiotics into Cuba, comprising 66% of global imports. The second position in the ranking was held by Brazil, with a 6.3% share of global imports. It was followed by Russia, with a 5.7% share.
In value terms, the United States remains the largest medicaments containing insulin supplier from Cuba, comprising 84% of global exports. The second position in the ranking was taken by Thailand, with a 0.6% share of global exports. It was followed by Denmark, with a 0.5% share.
The export price in Cuba stood at less than $0.1 per ton in 2021, flattening at the previous year.
The import price in Cuba stood at $128,871 per ton in 2021, standing approx. at the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Cuba. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • Cuba

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Cuba
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics - Cuba